Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput proteomics using antibody microarrays.

Christer Wingren1, Carl A K Borrebaeck

  • 1Department of Immunotechnology, Lund University, PO Box 7031, Lund, Sweden. christer.wingren@immun.lth.se

Expert Review of Proteomics
|June 22, 2005
PubMed
Summary

Antibody-based microarrays offer a novel proteomic tool for creating molecular fingerprints. This technology aids in biomarker discovery, drug target identification, and understanding disease biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost savings and quality-of-life gains associated with the use of an AI-powered digital tool for self-management of chronic pain based on a multicenter cohort study.

Pain medicine (Malden, Mass.)·2026
Same author

Multilayered Epigenetic Analysis Identifies a Molecular Portrait for Psychological Resilience in Patients With Breast Cancer.

Biological psychiatry global open science·2025
Same author

Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.

Cells·2024
Same author

An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain: a prospective, multicenter clinical trial.

Pain medicine (Malden, Mass.)·2023
Same author

One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life.

Frontiers in oncology·2022
Same author

Transcriptional profiling demonstrates altered characteristics of CD8<sup>+</sup> cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia.

Cancer medicine·2022

Area of Science:

  • Proteomics
  • Biotechnology
  • Molecular Biology

Background:

  • Antibody-based microarrays represent a novel technology with significant potential in proteomics.
  • This platform enables the printing of thousands of recombinant antibodies for specific analyte detection.

Purpose of the Study:

  • To explore the application of antibody-based microarrays for global proteome analysis.
  • To highlight the potential of this technology for biomarker discovery and disease diagnostics.

Main Methods:

  • Printing microarrays with thousands of recombinant antibodies.
  • Applying biologic samples (e.g., proteomes) to detect bound analytes.
  • Converting microarray patterns into proteomic maps or molecular fingerprints.

Related Experiment Videos

Main Results:

  • Generated proteomic maps reveal the composition of the proteome.
  • Enables global proteome analysis and protein expression profiling.
  • Demonstrates potential for biomarker discovery and drug target identification.

Conclusions:

  • Antibody-based microarrays are a promising tool for advancing proteomics research.
  • This technology offers new opportunities for disease diagnostics and understanding disease biology.
  • Ongoing development aims to establish this as a high-throughput proteomic tool.